Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal health in children with cystic fibrosis

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal health in children with cystic fibrosis

Resource Type

CF Research News

Authors

Nicole Green, Phuong Vu, Jing Xie, Sarah Jane Schwarzenberg, Steven Freedman, Michael Narkewicz, Jessica Pittman, Felix Ratjen, Margaret Rosenfeld, Christopher Pope, Jennifer Duong, Lucas Hoffman, Sonya Heltshe, Sarah S. Lusman

References

2026 Feb 14:S1569-1993(26)00034-2.  doi: 10.1016/j.jcf.2026.02.005

Document

File JCF-D-25-00463R1_FINAL_Green_19032026.docx [1]

Keywords

CFTR modulators [2]
Gastrointestinal [3]
Gastrointestinal symptoms [4]
Inflammation [5]
pancreatic insufficiency [6]
Patient-reported outcome measures [7]

Date

Sunday, February 22, 2026

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [8]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/impact-elexacaftortezacaftorivacaftor-gastrointestinal-health

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-25-00463R1_FINAL_Green_19032026.docx [2] https://www.ecfs.eu/research-article-keywords/cftr-modulators [3] https://www.ecfs.eu/research-article-keywords/gastrointestinal [4] https://www.ecfs.eu/research-article-keywords/gastrointestinal-symptoms [5] https://www.ecfs.eu/research-article-keywords/inflammation [6] https://www.ecfs.eu/research-article-keywords/pancreatic-insufficiency [7] https://www.ecfs.eu/research-article-keywords/patient-reported-outcome-measures-0 [8] https://www.ecfs.eu/resource-guideline-type/other-guidelines